SOUTHWEST ONCOLOGY GROUP

西南肿瘤集团

• 批准号: 7487227
• 负责人: THOMAS Patrick MILLER
• 金额: $ 2万
• 依托单位: UNIVERSITY OF ARIZONA
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-01-01 至 2009-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7487227
• 关键词: Affect; Arizona; Awareness; Cancer Center; Clinical Research; Clinical Trials; Disadvantaged; Discipline; Disease; Elderly; Funding; Human; Intervention; Laboratories; Leadership; Malignant Neoplasms; Minority; Patient Care; Patients; Physicians; Protocols documentation; Quality Control; Research; Services; Southwest Oncology Group; Testing; Universities; cancer therapy; improved; named group; outreach; quality assurance; repository

Funding is requested to support Arizona Cancer Center ( University of Arizona) participation in Southwest Oncology Group (SWOG) cooperative cancer clinical research to improve the treatment of cancer in humans. Specific aims and objectives are: 1. To continue to meet our current scientific leadership and core service commitments including: (a) protocol coordination (multiple studies); (b) disease and discipline committee administration; (c) reference and repository laboratory administration; (d) group quality assurance and quality control. 2. To continue to promote the rapid integration of promising new research leads, including those developed at the Arizona Cancer Center, into cooperative group testing to improve patient treatment options and patient care. 3. To continue to meet our institutional clinical research commitments in the recruitment of appropriate patients for SWOG and SWOG-endorsed studies and all attendant commitments to Iongterm followup, quality assurance, quality c ontrol, etc. 4. To continue to promote physician and patient awareness of and participation in SWOG and SWOG-endorsed clinical trials and outreach progr ares. 5. To continue efforts to understand factors affecting accrual, particularly those in special populations (eg, minority, elderly, financially disadvantaged), and to implement appropriate interventions where possible.

需要资金支持亚利桑那大学亚利桑那癌症中心参与西南地区 肿瘤学小组（SWOG）合作癌症临床研究，以改善癌症的治疗， 人类具体目标和目的是： 1.继续履行我们目前的科学领导地位和核心服务承诺，包括： (a)方案协调（多项研究）;（B）疾病和学科委员会管理; (c)参考和储存实验室管理;（d）小组质量保证和质量 控制 2.继续促进有前途的新的研究线索的快速整合，包括 在亚利桑那州癌症中心开发，进入合作小组测试，以改善患者 治疗选择和患者护理。 3.为了继续履行我们在招募临床研究人员方面的机构承诺， 适合SWOG和SWOG批准的研究的患者，以及所有相关承诺， 长期跟踪、质量保证、质量控制等。 4.继续促进医生和患者对SWOG的认识和参与， SWOG-endorsed临床试验和推广战神。 5.继续努力了解影响应计费用的因素，特别是特殊人群的因素 (eg、少数民族、老年人、经济困难者），并实施适当的干预措施 在可能的情况下。